Barostim Implantation with Ipsilateral Carotid Endarterectomy as a One-Stage Procedure

Kay F Weipert1, Astrid Most1, Oliver Doerr1

  • 1Division of Cardiology, Department of Internal Medicine I, Justus-Liebig University of Giessen, Giessen, Germany.

Insights

Baroreflex activation therapy (BAT) safely lowered blood pressure in a patient with carotid atherosclerosis after surgery. This approach offers a new option for resistant hypertension management in complex cases.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Medical Device Technology

Background:

  • Resistant hypertension management often involves invasive therapies.
  • Baroreflex activation therapy (BAT) uses carotid sinus stimulation for blood pressure reduction.
  • Carotid atherosclerosis has been a contraindication for BAT due to stroke risk.

Observation:

  • A patient with significant cerebral arteriosclerosis post-carotid endarterectomy was considered for BAT.
  • The procedure was performed as a one-stage implantation without neurologic complications.

Findings:

  • BAT was successfully and safely applied in this complex patient.
  • Satisfactory blood pressure reduction was maintained over an 18-month follow-up period.
  • The therapy proved effective despite the presence of cerebral arteriosclerosis.

Implications:

  • BAT may be a viable treatment option for resistant hypertension in patients with carotid atherosclerosis.
  • This case expands the potential patient population for baroreflex activation therapy.
  • Further research is warranted to confirm safety and efficacy in similar complex cases.

Related Concept Videos